By Will Boggs, MD NEW YORK (Reuters Health) – Temsirolimus does not improve progression-free survival in metastatic renal cell carcinoma (RCC) compared to standard treatment, according to results…
NEW YORK (Reuters Health) – In patients with potentially resectable colorectal liver metastases, the use of combined PET and CT imaging (PET-CT) identifies those with occult extrahepatic disease…
Recent Videos in Reuters Health • The Doctor’s Channel Newscast Page 86
NEW YORK (Reuters Health) – Patients with an implantable converter-defibrillator (ICD) that uses fracture-prone Fidelis leads have similar survival rates as ICD patients with another type of lead,…
NEW YORK (Reuters Health) – Patients with previously untreated multiple myeloma do better when they are given an autologous stem-cell transplant followed by an allogeneic transplant from a…
NEW YORK (Reuters Health) – Bronchodilation is well maintained in patients with chronic obstructive pulmonary disease (COPD) using the long-acting beta-2-agonist indacaterol during 1 year of treatment, investigators…
NEW YORK (Reuters Health) – Patients with arthritis acknowledge having thoughts of suicide twice as often as people without arthritis, researchers report. “Suicidal ideation is prevalent among adults…
NEW YORK (Reuters Health) – Patients with depression or diabetes have an increased risk of MI, but the risk is even higher in patients with both conditions, according…
NEW YORK (Reuters Health) – Among older women with breast cancer, specific comorbid conditions are independently associated with decreased survival, according to a report in the Journal of…
NEW YORK (Reuters Health) – African Americans are less likely to develop atrial fibrillation after isolated coronary artery bypass graft (CABG) surgery than European Americans, a new study…
NEW YORK (Reuters Health) – When performed at centers of excellence, robotic partial nephrectomy (RPN) has “an acceptably low” complication rate that mirrors that of open partial nephrectomy…
NEW YORK (Reuters Health) – Metformin beginning at the age of 8 years in girls at risk of polycystic ovary syndrome (PCOS) is more effective than a later…
NEW YORK (Reuters Health) – After six monthly intraocular injections of ranibizumab (Lucentis; Genentech) for macular edema, the benefits are maintained for another 6 months when ranibizumab is…
